NewAmsterdam Pharma Company NV - NAMS - stock price prediction, stock price target, analyst ratings from 9 analysts
NewAmsterdam Pharma Company NV has a share price target of US$ 45, revenue growth forecast of -61.7%, and profit growth estimate of 13.5% for FY25, based on top 9 analyst calls.